Summary
A study was conducted to investigate the cumulative survival rates among groups of patients with liver cirrhosis who were stratified by plasma branched-chain amino acid (BCAA)/aromatic amino acid (AAA) molar ratio (BCAA/AAA), and to evaluate the effect of long-term oral supplementation with BCAA on the prognosis of cirrhotics with noticeably lower BCAA/AAA molar ratio. When 104 patients with liver cirrhosis were divided into three groups on the basis of BCAA/AAA molar ratio, i.e. BCAA/AAA≧l.8 (Group 1), 1.8>BCAA/AAA≧1.0 (Group 2), and 1.0>BCAA/AAA (Group 3), Group 1 showed the highest cumulative survival rate, followed respectively by Groups 2 and 3 (P<0.05). In 20 cases of non-alcloholic liver cirrhosis having BCAA/AAA<1.8, oral supplementation with branchedchain amino acid granules (BCAA-G) for 6 months or more (median 27 months, range 7–62 months) brought about significant increase of plasma BCAA concentration, BCAA/AAA molar ratio, and serum albumin concentration. Furthermore, the 20 cases with BCAA-G supplementation showed significantly higher cumulative survival rate during 2–4 years as compared to the control cases matched for age, sex, and etiology (involvement of hepatitis B virus). These findings indicate that long-term oral supplementation with BCAA to cirrhotic patients provides beneficial effect on the prognosis by improving protein malnutritional status and consequently delaying fatal complications such as hepatic failure and gastrointestinal bleeding.
Similar content being viewed by others
References
Morgan MY, Milson JP, Sherlock S: Plasma ratio of valine, leucine and isoleucine to phenylalanine and tyrosine in liver diseases. Gut 1978;19:1068–1073
Muto Y, Yoshida T, Yamatoh M: Clinical assessment of nutritional status in patients with liver cirrhosis with special reference to plasma amino acid imbalance. J Clin Biochem Nutr 1986;l:89–95
Fischer JE, Rosen HM, Ebei AM, et al: The effect of normalization of plasma amino acids on hepatic encephalopathy in man. Surgery 1976;80:77–91
Freund H, Dienstag J, Lehrig J, et al: Infusion of branchedchain enriched amino acid solution in patients with hepatic encephalopathy. Ann Surg 1982;196:89–95
Horst D, Crace ND, Conn HO, et al: Comparison of dietary protein with an oral, branched chain-enriched amino acid supplement in chronic portal-systemic encephalopathy: a randomized controlled trial. Hepatology 1984;4:279–287
Cerra FB, Cheung NK, Fischer JE, et al: Disease-specific amino acid infusion (F080) in hepatic encephalopathy: a prospective randomized, double-blind, controlled trial. J Parent Ent Nutr 1985;9:288–295
Marchesini G, Zoli M, Dondi C, et al: Anticatabolic effect of branched-chain amino acid-enriched solutions in patients with liver cirrhosis. Hepatology 1982;2:420–425
Eriksson LS: Branched-chain amino acids in the treatment of hepatic encephalopathy. In; Conn HO, Bircher J, ed. Hepatic Encephalopathy: Management with lactulose and related carbohydrates. Medi-Ed Press, East Lansing 1988;129–141
Conn HO: A peek at the Child-Turcotte classification. Hepatology 1981;l:673–676
Mondzac A, Ehrlich GE, Seegmiller JE: An enzymatic determination of ammonia in biological fluids. J Lab Clin Med 1965;66:526–531
Kaplan EL, Meier P: Nonparametric estimation for incomplete observations. J Am Stat Assoc 1958;53:457–481
Peto R, Pike MC, Armitage NE, et al: Design and analysis of randomized clinical trials requiring prolonged observations of each patients. II. Analysis and examples. Br J Cancer 1977;35:1–39
Joint FAO/WHO Ad Hoc Expert Committee: Energy and protein requirements. WHO Tech Rep Ser 1983;522:40–72
Ichihara A, Koyama E: Transaminase of branched-chain amino acids. I. Branched chain amino acids ketoglutamate transaminase. J Biochem 1966;59:160–169
Muto Y, Yoshida T: Effect of oral supplementation with branched-chain amino acid granules on improvement of protein nutrition in decompensated liver cirrhosis: a crossover controlled study. In: Ogoshi S, Okada A, eds. Parenteral and enterai hyperalimentation. Elsevier, Amsterdom. 1984;280–292
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Yoshida, T., Muto, Y., Moriwaki, H. et al. Effect of long-term oral supplementation with branched-chain amino acid granules on the prognosis of liver cirrhosis. Gastroenterol Jpn 24, 692–698 (1989). https://doi.org/10.1007/BF02774169
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02774169